Showing results (131-140 of 190) with videos related to
Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancerAman Buzdar, Joyce A O'Shaughnessy, Daniel J Booser, et al.Human Gene Therapy|July 1, 1994
Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancerJ A O'Shaughnessy, K H Cowan, A W Nienhuis, et al.Marine Pollution Bulletin|June 9, 2020
Recovery of an urbanised estuary: Clean-up, de-industrialisation and restoration of redundant dock-basins in the MerseyS J Hawkins, K A O'Shaughnessy, L A Adams, et al.NPJ Breast Cancer|December 4, 2025
Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinionNeil M Iyengar, Joyce A O'Shaughnessy, Heather B Moore, et al.Breast Cancer Research and Treatment|December 29, 2010
Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancerNicholas J Robert, Paul R Conkling, Mark A O'Rourke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trialsJ A O'Shaughnessy, R E Wittes, G Burke, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 29, 2004
Hypertension after kidney transplantationBertram L Kasiske, Shakeel Anjum, Rajiv Shah, et al.Clinical Breast Cancer|July 16, 2008
Phase II trial of gemcitabine/carboplatin (plus trastuzumab in HER2-positive disease) in patients with metastatic breast cancerDavid Loesch, Lina Asmar, Kristi McIntyre, et al.Breast Cancer Research and Treatment|January 14, 2009
The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancerCynthia R Osborne, Anita Duncan, Scot Sedlacek, et al.Molecular Cancer Research : MCR|September 2, 2018
Genomic Alterations Associated with Recurrence and TNBC Subtype in High-Risk Early Breast CancersTimothy R Wilson, Akshata R Udyavar, Ching-Wei Chang, et al.Pageof 19